Renalytix Plc (RTNXF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 01:47PM EDT
| Previous close | 0.6212 |
| Open | 0.6212 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.6212 - 0.6212 |
| 52-week range | 0.1540 - 1.9100 |
| Volume | |
| Avg. volume | 283 |
| Market cap | 91.651M |
| Beta (5Y monthly) | 1.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Fool.co.uk
Is Renalytix the best penny stock to buy today?
The Renalytix share price erupted this week as the AI diagnostics firm received a takeover bid. But is it too late to buy this penny stock? The post Is Renalytix the best penny stock to buy today? appeared first on The Motley Fool UK.
- Zacks
What Makes Renalytix AI PLC Sponsored ADR (RNLX) a New Strong Buy Stock
Renalytix AI PLC Sponsored ADR (RNLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Renalytix AI PLC Sponsored ADR (RNLX) Loses -44.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Renalytix AI PLC Sponsored ADR (RNLX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
© 2024 Yahoo. All rights reserved.